Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

AOD-9604 and BPC-157 Interaction: Compatible | Peptide Database

Can you take AOD-9604 with BPC-157? Compatible interaction (90% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

AOD-9604

Modified hGH Fragment | Fat Loss Peptide

Stimulates lipolysis and inhibits lipogenesis through beta-3 adrenergic receptor upregulation, without binding to the GH receptor. Does not affect glucose metabolism or increase IGF-1 levels.

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take AOD-9604 with BPC-157?

Yes, AOD-9604 and BPC-157 can generally be taken together. Different mechanisms; sometimes combined for comprehensive healing.

Is AOD-9604 and BPC-157 safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between AOD-9604 and BPC-157?

Different mechanisms; sometimes combined for comprehensive healing. This assessment has 90% confidence and is based on documented research data.

How should I time AOD-9604 and BPC-157?

AOD-9604 has a half-life of 3-4 minutes and BPC-157 has a half-life of <30 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question